Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

NFE2L2 and ferroptosis resistance in cancer therapy

Cancer Drug Resistance(2024)10.20517/cdr.2024.123Source: DataRank Database

NFE2L2 and ferroptosis resistance in cancer therapy is a research paper published in Cancer Drug Resistance (2024). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (6)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Rui Kang ORCID,Daolin Tang ORCID

Live enrichment

PubMed:39534872 PMC:PMC11555182

National Institutes of Health

Grant: 5R01CA211070-02

The Pancreatic Cancer Microenvironment

National Institutes of Health

Grant: 5R01CA229275-05

Mechanisms of Ferroptotic Cancer Cell Death

National Institutes of Health

Grant: 5R01CA160417-09

Mitophagy in Tumor Microenvironment

goldLicense: http://creativecommons.org/licenses/by/4.0/© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

publisherhttps://www.oaepublish.com/articles/cdr.2024.123

Unpaywallhttps://doi.org/10.20517/cdr.2024.123

Europe_PMChttps://europepmc.org/articles/PMC11555182

Europe_PMChttps://europepmc.org/articles/PMC11555182?pdf=render

https://pubmed.ncbi.nlm.nih.gov/39534872

Keywords

Drug resistanceOxidative stressCancer therapyNfe2l2FerroptosisReview